UK markets closed

Panacea Biotec Limited (PANACEABIO.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
132.70-0.40 (-0.30%)
At close: 03:29PM IST
Currency in INR

Valuation measures4

Market cap (intra-day) 8.12B
Enterprise value 6.48B
Trailing P/E 0.61
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.48
Price/book (mrq)0.96
Enterprise value/revenue 1.01
Enterprise value/EBITDA 0.28

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 312.13%
S&P500 52-week change 326.27%
52-week high 3202.50
52-week low 3114.20
50-day moving average 3138.68
200-day moving average 3153.08

Share statistics

Avg vol (3-month) 3176.15k
Avg vol (10-day) 365.11k
Shares outstanding 561.25M
Implied shares outstanding 661.34M
Float 814.95M
% held by insiders 173.76%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 419 Sept 2011
Last split factor 210:1
Last split date 303 Feb 2003

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -2.12%
Operating margin (ttm)-2.38%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)5.52B
Revenue per share (ttm)51.72
Quarterly revenue growth (yoy)30.60%
Gross profit (ttm)N/A
EBITDA -88.85M
Net income avi to common (ttm)-116.77M
Diluted EPS (ttm)-1.99
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.82B
Total cash per share (mrq)30.57
Total debt (mrq)206.8M
Total debt/equity (mrq)2.45%
Current ratio (mrq)N/A
Book value per share (mrq)137.93

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A